mi-730 microoxygen electrode (Microelectrodes Inc)
90
Structured Review
Microelectrodes Inc
mi-730 microoxygen electrode
Mi 730 Microoxygen Electrode, supplied by Microelectrodes Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mi-730+microoxygen+electrode/micro+oxygen+electrode+mi+730/10__1002_slash_adfm__201404511-388-69-74
Average 90 stars, based on 1 article reviews
Mi 730 Microoxygen Electrode, supplied by Microelectrodes Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mi-730+microoxygen+electrode/micro+oxygen+electrode+mi+730/10__1002_slash_adfm__201404511-388-69-74
Average 90 stars, based on 1 article reviews
mi-730 microoxygen electrode - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Laser Capture Microdissection:Article Title: Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Article Snippet: We evaluated the efficacy of cycloheximide, heat stress, NMDA receptor blockade (MK801/AP-5), oxygen–glucose deprivation, hypoxia, hypothermia and TNFa preconditioning to protect cortical neurons from in vitro ischemic insults that result in acute necrotic and delayed apoptotic neuronal death.. Preconditioning treatments were performed 22–24 h before in vitro ischemia.. In vitro ischemia was carried out in 96-well microtitre strip-plates by washing neuronal cultures with a balanced salt solution containing 25 mM 2-deoxy-Dglucose and incubating in an anaerobic chamber. Article Title: Design of Hybrid MnO2-Polymer-Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment Article Snippet: Hypoxia (lack of oxygen) is a common characteristic of the tumor microenvironment (TME) and a negative clinical prognostic factor for a variety of solid tumors due to its critical role in tumor progression, metastasis, and resistance to mainline treatments.. [ 1 ] Tumor hypoxia is at least partially responsible for the stabilization of hypoxia-inducible-factor-1alpha (HIF1α), a transcription factor that switches on a cascade of harmful gene and protein expression and metabolic changes in the tumor.. [ 2–4 ] The metabolic changes driven by hypoxia promote acidosis (acidic pH in the tumor) and increased rates of reactive oxygen species (ROS) production contributing to an even more abnormal TME. Saline:Article Title: Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Article Snippet: We evaluated the efficacy of cycloheximide, heat stress, NMDA receptor blockade (MK801/AP-5), oxygen–glucose deprivation, hypoxia, hypothermia and TNFa preconditioning to protect cortical neurons from in vitro ischemic insults that result in acute necrotic and delayed apoptotic neuronal death.. Preconditioning treatments were performed 22–24 h before in vitro ischemia.. In vitro ischemia was carried out in 96-well microtitre strip-plates by washing neuronal cultures with a balanced salt solution containing 25 mM 2-deoxy-Dglucose and incubating in an anaerobic chamber. Article Title: Design of Hybrid MnO2-Polymer-Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment Article Snippet: Hypoxia (lack of oxygen) is a common characteristic of the tumor microenvironment (TME) and a negative clinical prognostic factor for a variety of solid tumors due to its critical role in tumor progression, metastasis, and resistance to mainline treatments.. [ 1 ] Tumor hypoxia is at least partially responsible for the stabilization of hypoxia-inducible-factor-1alpha (HIF1α), a transcription factor that switches on a cascade of harmful gene and protein expression and metabolic changes in the tumor.. [ 2–4 ] The metabolic changes driven by hypoxia promote acidosis (acidic pH in the tumor) and increased rates of reactive oxygen species (ROS) production contributing to an even more abnormal TME. Injection:Article Title: Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Article Snippet: We evaluated the efficacy of cycloheximide, heat stress, NMDA receptor blockade (MK801/AP-5), oxygen–glucose deprivation, hypoxia, hypothermia and TNFa preconditioning to protect cortical neurons from in vitro ischemic insults that result in acute necrotic and delayed apoptotic neuronal death.. Preconditioning treatments were performed 22–24 h before in vitro ischemia.. In vitro ischemia was carried out in 96-well microtitre strip-plates by washing neuronal cultures with a balanced salt solution containing 25 mM 2-deoxy-Dglucose and incubating in an anaerobic chamber. Article Title: Design of Hybrid MnO2-Polymer-Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment Article Snippet: Hypoxia (lack of oxygen) is a common characteristic of the tumor microenvironment (TME) and a negative clinical prognostic factor for a variety of solid tumors due to its critical role in tumor progression, metastasis, and resistance to mainline treatments.. [ 1 ] Tumor hypoxia is at least partially responsible for the stabilization of hypoxia-inducible-factor-1alpha (HIF1α), a transcription factor that switches on a cascade of harmful gene and protein expression and metabolic changes in the tumor.. [ 2–4 ] The metabolic changes driven by hypoxia promote acidosis (acidic pH in the tumor) and increased rates of reactive oxygen species (ROS) production contributing to an even more abnormal TME. Generated:Article Title: Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Article Snippet: We evaluated the efficacy of cycloheximide, heat stress, NMDA receptor blockade (MK801/AP-5), oxygen–glucose deprivation, hypoxia, hypothermia and TNFa preconditioning to protect cortical neurons from in vitro ischemic insults that result in acute necrotic and delayed apoptotic neuronal death.. Preconditioning treatments were performed 22–24 h before in vitro ischemia.. In vitro ischemia was carried out in 96-well microtitre strip-plates by washing neuronal cultures with a balanced salt solution containing 25 mM 2-deoxy-Dglucose and incubating in an anaerobic chamber. Article Title: Design of Hybrid MnO2-Polymer-Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment Article Snippet: Hypoxia (lack of oxygen) is a common characteristic of the tumor microenvironment (TME) and a negative clinical prognostic factor for a variety of solid tumors due to its critical role in tumor progression, metastasis, and resistance to mainline treatments.. [ 1 ] Tumor hypoxia is at least partially responsible for the stabilization of hypoxia-inducible-factor-1alpha (HIF1α), a transcription factor that switches on a cascade of harmful gene and protein expression and metabolic changes in the tumor.. [ 2–4 ] The metabolic changes driven by hypoxia promote acidosis (acidic pH in the tumor) and increased rates of reactive oxygen species (ROS) production contributing to an even more abnormal TME. |